We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Polystyrene microplastic induced airway hyper-responsiveness, and pulmonary inflammation are mitigated by bronchom treatment in murine model of lung disease
Summary
Researchers exposed mice to polystyrene microplastics and found that the particles triggered airway hyper-responsiveness, lung inflammation, and structural damage similar to asthma-like symptoms. An herbal medicine called Bronchom, given as a pre-treatment, significantly reduced these harmful effects by lowering inflammatory cell counts and cytokine levels in the lungs. The study suggests that microplastic inhalation can cause meaningful respiratory problems and identifies a potential natural approach for mitigating lung inflammation caused by microplastic exposure.
Microplastics are global menace-associated with respiratory damages. The objective of this study was to investigate the airway hyper-responsiveness (AHR) and inflammation induced by polystyrene microplastic (PSMPs) in male C57BL/6 mice and its modulation by 'Bronchom', an herbal medicine. For the study, animals were pre-treated with varying doses of Bronchom before 21-day exposure to PSMPs, followed by assessment of pulmonary damages. PSMPs exposure in mice significantly induced AHR to methacholine, represented by elevated respiratory resistance, and reduced lung compliance. PSMPs also induced influx of pro-inflammatory cells and release of pro-inflammatory mediators TNF-α, IL-1β, IL-5, IL-6 and MIP-2α in the bronchoalveolar lavage of PSMPs-exposed animals. Histopathological analysis confirmed leukocyte infiltration and mild fibrosis in the lung tissues of PSMPs-exposed animals. PSMPs-exposure also enhanced mRNA expression of pro-inflammatory biomarkers in lung tissues. Bronchom-treated mice showed significant protection against the PSMPs-induced AHR, inflammatory cell influx and cytokine expression, along with histopathological changes in dose-dependent manner. Pirfenidone used as a positive control showed beneficiary effects against PSMPs-induced respiratory distress. Interestingly, FTIR spectroscopy of the Bronchom-treated mice lung tissues indicated dose-dependent reduction in PSMPs-specific transmittance signatures, suggesting their reduced bioaccumulation. In human THP-1 macrophages, Bronchom also attenuated PSMPs-induced TNF-α and IL-6 cytokines release. Ultra-high-performance-liquid-chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QToF-MS) identified 80 phytochemicals, associated with robust anti-inflammatory and anti-oxidant profile. These results indicated that Bronchom effectively mitigates PSMPs-induced respiratory distress-associated inflammation and PSMPs bioaccumulation in lung tissue, likely due to its rich phytochemical composition. This study highlights Bronchom as a promising herbal intervention against microplastic-associated pulmonary ailments.
Sign in to start a discussion.
More Papers Like This
Detrimental effects of microplastic exposure on normal and asthmatic pulmonary physiology
Researchers exposed both healthy and asthmatic mice to airborne microplastics and found significant lung inflammation, immune activation, and increased mucus production in both groups. Microplastic particles were taken up by immune cells called macrophages, and gene analysis revealed changes in immune response, cellular stress, and cell death pathways. The study suggests that inhaling microplastics may worsen respiratory health in both normal and vulnerable populations.
Reformulating asthma therapy through nano-phytomedicine: Insights into lung health and microplastic exposure
This review examines the use of nanotechnology-based phytomedicine formulations to improve asthma treatment, while also exploring how microplastic inhalation contributes to lung inflammation and airway dysfunction, framing microplastic exposure as a key driver of rising asthma prevalence.
Impact of Microplastic Exposure on Airway Inflammation in an Acute Asthma Murine Model
Mouse experiments found that microplastic exposure worsened inflammatory responses in healthy lungs but did not further aggravate airway inflammation in mice with pre-existing asthma, suggesting the lung's response to microplastics depends on baseline immune state.
Oropharyngeal Administration of Polystyrene Microplastics Induces Profibrotic and Oxidative Changes in Murine Lung Tissue
Researchers investigated the early lung effects of inhaled polystyrene microplastics in mice over a 21-day exposure period. While overall fibrosis scores did not reach statistical significance in this short timeframe, they observed significant macrophage infiltration, active particle uptake by immune cells, and upregulation of oxidative stress and fibrosis-related molecular markers. The findings suggest that microplastic inhalation triggers early immune and oxidative responses that may precede lung tissue remodeling.
Polystyrene particles induces asthma-like Th2-mediated lung injury through IL-33 secretion
Researchers found that inhaled polystyrene microplastic particles triggered asthma-like inflammation in the lungs of mice, with smaller particles causing more severe responses. The particles stimulated the release of IL-33, a signaling molecule that activates a specific type of immune response associated with allergic airway disease. The study identifies a potential mechanism by which airborne microplastics could contribute to respiratory inflammation.